358 related articles for article (PubMed ID: 17721184)
1. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
2. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.
Saito T; Oda Y; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
J Pathol; 2001 Sep; 195(2):222-8. PubMed ID: 11592102
[TBL] [Abstract][Full Text] [Related]
3. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
4. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
Tejpar S; Nollet F; Li C; Wunder JS; Michils G; dal Cin P; Van Cutsem E; Bapat B; van Roy F; Cassiman JJ; Alman BA
Oncogene; 1999 Nov; 18(47):6615-20. PubMed ID: 10597266
[TBL] [Abstract][Full Text] [Related]
5. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
[TBL] [Abstract][Full Text] [Related]
6. APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
Latchford A; Volikos E; Johnson V; Rogers P; Suraweera N; Tomlinson I; Phillips R; Silver A
Hum Mol Genet; 2007 Jan; 16(1):78-82. PubMed ID: 17135276
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
Hauben EI; Jundt G; Cleton-Jansen AM; Yavas A; Kroon HM; Van Marck E; Hogendoorn PC
Hum Pathol; 2005 Sep; 36(9):1025-30. PubMed ID: 16153468
[TBL] [Abstract][Full Text] [Related]
8. Superficial fibromatoses are genetically distinct from deep fibromatoses.
Montgomery E; Lee JH; Abraham SC; Wu TT
Mod Pathol; 2001 Jul; 14(7):695-701. PubMed ID: 11455002
[TBL] [Abstract][Full Text] [Related]
9. Codon 45 of the beta-catenin gene, a specific mutational target site of Wilms' tumor.
Kusafuka T; Miao J; Kuroda S; Udatsu Y; Yoneda A
Int J Mol Med; 2002 Oct; 10(4):395-9. PubMed ID: 12239584
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
11. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
[TBL] [Abstract][Full Text] [Related]
12. Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation.
Kitazawa S; Kitazawa R; Obayashi C; Yamamoto T
J Bone Miner Res; 2005 Aug; 20(8):1472-7. PubMed ID: 16007344
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
14. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).
Tejpar S; Li C; Yu C; Poon R; Denys H; Sciot R; Van Cutsem E; Cassiman JJ; Alman BA
Br J Cancer; 2001 Jul; 85(1):98-101. PubMed ID: 11437409
[TBL] [Abstract][Full Text] [Related]
15. A gene expression signature that distinguishes desmoid tumours from nodular fasciitis.
Bacac M; Migliavacca E; Stehle JC; McKee T; Delorenzi M; Coindre JM; Guillou L; Stamenkovic I
J Pathol; 2006 Mar; 208(4):543-53. PubMed ID: 16440290
[TBL] [Abstract][Full Text] [Related]
16. [Adenomatous polyposis coli gene and beta-catenin gene mutations in desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):237-8. PubMed ID: 16776983
[No Abstract] [Full Text] [Related]
17. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA
Oncogene; 2001 Jan; 20(4):451-60. PubMed ID: 11313976
[TBL] [Abstract][Full Text] [Related]
18. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
Ferenc T; Sygut J; Kopczyński J; Mayer M; Latos-Bieleńska A; Dziki A; Kulig A
Pol J Pathol; 2006; 57(1):5-15. PubMed ID: 16739877
[TBL] [Abstract][Full Text] [Related]
19. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
Couture J; Mitri A; Lagace R; Smits R; Berk T; Bouchard HL; Fodde R; Alman B; Bapat B
Clin Genet; 2000 Mar; 57(3):205-12. PubMed ID: 10782927
[TBL] [Abstract][Full Text] [Related]
20. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer.
Ogasawara N; Tsukamoto T; Mizoshita T; Inada K; Cao X; Takenaka Y; Joh T; Tatematsu M
Histopathology; 2006 Dec; 49(6):612-21. PubMed ID: 17163846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]